FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
24/06/2026
Voltar para busca
Dado oficial do USPTO
SMARTROUTE
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
32
Atualização mais recente
24/06/2026
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
42
Data de depósito
27/12/2023
Data de registro
24/03/2026
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
24/03/2026
Última transação
24/06/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
16
Localização do titular
SI
Examinador
LOZEAU, BRANDON THOMAS
Unidade examinadora
N90
Localização atual
FILE REPOSITORY (FRANCONIA)
Titulares e representantes
Titulares
A. D. (pessoa física)
Representantes
Jennifer Fraser Dykema Gossett PLLC
Classificação técnica
Classes Nice
Classe 42
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 42
Scientific and technological research and design servicesdevelopment and planning of manufacturing processes for the production of vitaminsfood supplements for humans and animalsbio pesticides and chemicals; biotechnological and pharmaceutical research; consultancy related to biotechnology; development in the field of biotechnology and pharmaceuticals; engineering; scientific research in the field of genetics and genetic engineering; biological cloning services; development and research in the field of microbial biotechnology; scientific and technological researchdevelopment and testing services in the field of biotechnologybiochemistrymicrobiology and molecular science; biological researchclinical research in the fields of genetic studies and medical research; industrial analysis of bioproducts and research in the field of bioproduction; research and development of industrial process; chemical technological research; development of new technologies for others in the field of pharmaceuticalchemical and agri-food industries; product development for others; design of production methods; custom development of new chemical and biological strains for use in the chemicalpharmaceuticalagriculture industries; custom development of new genesproteins and protein fractions for use in chemistrypharmaceuticalsagriculturediagnosticsmedicine and industry; algorithm-supported custom design and development of chemical and biological strains and fermentation media; testingauthentication and quality control of molecules for others in the field of microscopy; biological research laboratory services; vaccine development and testing; monitoringcontrollingassessing and consulting with reference to biohazards for scientific research purposes; biologicalmicrobiologicalpathogenic and viral screening and testing services for scientific research purposes; collectingmaintaining and providing access to bacterial cultures and bacterial isolates for scientific and research purposes; pharmaceutical research; analysis and developments in the field of molecular biology for scientific research purposes; biomedical research services; DNA sequencing for medical research purposes; scientific laboratory servicespreparation of biological samples for analysis in research laboratories; research services in the field of proteinsantibodiesmicroorganisms and cells; development of pharmaceutical preparationsmedicinesbiological moleculesstem cellsgenesvaccinesbacteriaviruses; scientific and technological research and design servicesdevelopment of final downstream processing in the production of microbial production strains in the field of pharmacybiotechnologygeneticsbiochemistrymicrobiology and molecular sciences; research services in the field of cell separation and pharmaceutical drug purification; scientific laboratory services related to the isolation and cultivation of human tissues and cells; scientific laboratory servicespreparation of biological samples for research purposes.
Publicações
Histórico de despachos e eventos da marca no USPTO.
32 publicações encontradas
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
24/03/2026
R.PR
REGISTERED-PRINCIPAL REGISTER
24/03/2026
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
03/02/2026
PUBO
PUBLISHED FOR OPPOSITION
03/02/2026
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
28/01/2026
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
13/01/2026
XAEC
EXAMINER'S AMENDMENT ENTERED
13/01/2026
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
13/01/2026
GNEA
EXAMINERS AMENDMENT E-MAILED
13/01/2026
CNEA
EXAMINERS AMENDMENT -WRITTEN
13/01/2026
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
31/10/2025
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
15/10/2025
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
15/10/2025
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
01/07/2025
GNFR
FINAL REFUSAL E-MAILED
01/07/2025
CNFR
FINAL REFUSAL WRITTEN
01/07/2025
ZZZX
PREVIOUS ALLOWANCE COUNT WITHDRAWN
09/06/2025
PBCR
WITHDRAWN FROM PUB - OG REVIEW QUERY
03/06/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
10/05/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
28/04/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
28/04/2025
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
28/04/2025
RFNT
REFUSAL PROCESSED BY IB
23/11/2024
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
04/11/2024
RFRR
REFUSAL PROCESSED BY MPU
04/11/2024
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
30/10/2024
CNRT
NON-FINAL ACTION WRITTEN
29/10/2024
DOCK
ASSIGNED TO EXAMINER
25/07/2024
MAFR
APPLICATION FILING RECEIPT MAILED
22/05/2024
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
22/05/2024
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
16/05/2024
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace SMARTROUTE ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.